Consumer Defensive - Household & Personal Products - NYSE - US
$ 7.58
5.42 %
$ 377 M
Market Cap
-3.63
P/E
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements.[ Read More ]
The intrinsic value of one NUS stock under the base case scenario is HIDDEN Compared to the current market price of 7.58 USD, Nu Skin Enterprises, Inc. is HIDDEN
2. FUNDAMENTAL
ANALYSIS
Price Chart NUS
FINANCIALS
1.97 B
REVENUE
48.3 M
OPERATING INCOME
8.6 M
NET INCOME
119 M
OPERATING CASH FLOW
-135 M
INVESTING CASH FLOW
10.7 M
FINANCING CASH FLOW
430 M
REVENUE
18.2 M
OPERATING INCOME
8.3 M
NET INCOME
31.4 M
OPERATING CASH FLOW
-6.55 M
INVESTING CASH FLOW
-28.8 M
FINANCING CASH FLOW
Balance Sheet Decomposition
Nu Skin Enterprises, Inc.
| Current Assets | 702 M |
| Cash & Short-Term Investments | 268 M |
| Receivables | 72.9 M |
| Other Current Assets | 361 M |
| Non-Current Assets | 1.1 B |
| Long-Term Investments | 40.1 M |
| PP&E | 523 M |
| Other Non-Current Assets | 541 M |
| Current Liabilities | 329 M |
| Accounts Payable | 43.5 M |
| Short-Term Debt | 48.9 M |
| Other Current Liabilities | 236 M |
| Non-Current Liabilities | 656 M |
| Long-Term Debt | 558 M |
| Other Non-Current Liabilities | 97.2 M |
EFFICIENCY
Earnings Waterfall
Nu Skin Enterprises, Inc.
| Revenue | 1.97 B |
| Cost Of Revenue | 612 M |
| Gross Profit | 1.36 B |
| Operating Expenses | 1.29 B |
| Operating Income | 48.3 M |
| Other Expenses | 39.7 M |
| Net Income | 8.6 M |
RATIOS
68.93%
GROSS MARGIN
2.45%
OPERATING MARGIN
0.44%
NET MARGIN
1.05%
ROE
0.48%
ROA
1.18%
ROIC
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Nu Skin Enterprises, Inc.
| Net Income | 8.6 M |
| Depreciation & Amortization | 69.6 M |
| Capital Expenditures | -58.5 M |
| Stock-Based Compensation | 15.6 M |
| Change in Working Capital | -81.7 M |
| Others | 88.9 M |
| Free Cash Flow | 60.1 M |
Wall Street Analysts Price Targets
Nu Skin Enterprises, Inc.
Wall Street analysts predict an average 1-year price target for NUS of $11 , with forecasts ranging from a low of $11 to a high of $11 .
NUS Lowest Price Target
Wall Street Target
11 USD
45.12%
NUS Average Price Target
Wall Street Target
11 USD
45.12%
NUS Highest Price Target
Wall Street Target
11 USD
45.12%
4. DIVIDEND ANALYSIS
0.81%
DIVIDEND YIELD
0.06 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Nu Skin Enterprises, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
26.7 K USD 1
6-9 MONTHS
94.6 K USD 2
9-12 MONTHS
110 K USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
5 months ago
May 28, 2024
|
Sell 26.7 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
13.33 USD |
|
6 months ago
May 02, 2024
|
Sell 20.3 K USD
|
WOODBURY EDWINA D
Director |
- 1693
|
12.02 USD |
|
6 months ago
Apr 25, 2024
|
Sell 24.7 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
12.34 USD |
|
7 months ago
Mar 25, 2024
|
Sell 24.6 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
12.32 USD |
|
8 months ago
Feb 26, 2024
|
Sell 24.9 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
12.46 USD |
|
9 months ago
Jan 25, 2024
|
Sell 37.1 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
18.55 USD |
|
10 months ago
Dec 26, 2023
|
Sell 38.8 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
19.39 USD |
|
11 months ago
Nov 27, 2023
|
Sell 34.2 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
17.11 USD |
|
1 year ago
Nov 03, 2023
|
Sell 272 K USD
|
LIPMAN ANDREW D
Director |
- 15400
|
17.68 USD |
|
1 year ago
Oct 25, 2023
|
Sell 38.5 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
19.23 USD |
|
1 year ago
Sep 25, 2023
|
Sell 46 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
23.02 USD |
|
1 year ago
Aug 25, 2023
|
Sell 46.7 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
23.33 USD |
|
1 year ago
Aug 21, 2023
|
Sell 146 K USD
|
Nathanson Laura
Director |
- 6068
|
24.12 USD |
|
1 year ago
Aug 07, 2023
|
Sell 33.3 K USD
|
Battle Emma S.
Director |
- 1272
|
26.15 USD |
|
1 year ago
Jul 25, 2023
|
Sell 58 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
28.99 USD |
|
1 year ago
Jun 26, 2023
|
Sell 64.2 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
32.12 USD |
|
1 year ago
May 25, 2023
|
Sell 68.6 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
34.28 USD |
|
1 year ago
May 09, 2023
|
Sell 47.5 K USD
|
WOODBURY EDWINA D
Director |
- 1255
|
37.87 USD |
|
1 year ago
Apr 25, 2023
|
Sell 81.5 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
40.75 USD |
|
1 year ago
Mar 27, 2023
|
Sell 78.6 K USD
|
LIPMAN ANDREW D
Director |
- 2000
|
39.29 USD |
|
1 year ago
Mar 09, 2023
|
Sell 842 K USD
|
Hatchett Steven Keith
Chief Product Officer |
- 21155
|
39.78 USD |
|
1 year ago
Mar 02, 2023
|
Sell 1.07 M USD
|
Lawrence Mark H
Chief Financial Officer |
- 26144
|
40.8 USD |
|
1 year ago
Mar 02, 2023
|
Sell 1.02 M USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 25000
|
40.77 USD |
|
1 year ago
Mar 01, 2023
|
Sell 2.77 M USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 68485
|
40.44 USD |
|
1 year ago
Feb 28, 2023
|
Sell 380 K USD
|
NAPIERSKI RYAN S
President and CEO |
- 9400
|
40.38 USD |
|
1 year ago
Feb 27, 2023
|
Sell 890 K USD
|
NAPIERSKI RYAN S
President and CEO |
- 21513
|
41.38 USD |
|
1 year ago
Feb 28, 2023
|
Sell 24.6 K USD
|
NAPIERSKI RYAN S
President and CEO |
- 600
|
40.97 USD |
|
1 year ago
Feb 22, 2023
|
Sell 41.2 K USD
|
Battle Emma S.
Director |
- 987
|
41.7 USD |
|
1 year ago
Feb 22, 2023
|
Sell 41.4 K USD
|
LIPMAN ANDREW D
Director |
- 1000
|
41.42 USD |
|
1 year ago
Feb 23, 2023
|
Sell 116 K USD
|
Thomas James D
Chief Accounting Officer |
- 2829
|
41.12 USD |
|
1 year ago
Jan 23, 2023
|
Sell 42.3 K USD
|
LIPMAN ANDREW D
Director |
- 1000
|
42.27 USD |
|
1 year ago
Dec 22, 2022
|
Sell 40.8 K USD
|
LIPMAN ANDREW D
Director |
- 1000
|
40.75 USD |
|
1 year ago
Nov 25, 2022
|
Sell 961 K USD
|
NAPIERSKI RYAN S
President and CEO |
- 25000
|
38.45 USD |
|
1 year ago
Nov 22, 2022
|
Sell 38.2 K USD
|
LIPMAN ANDREW D
Director |
- 1000
|
38.16 USD |
|
2 years ago
Oct 21, 2022
|
Sell 35.9 K USD
|
LIPMAN ANDREW D
Director |
- 1000
|
35.92 USD |
|
2 years ago
Sep 22, 2022
|
Sell 36.7 K USD
|
LIPMAN ANDREW D
Director |
- 1000
|
36.67 USD |
|
2 years ago
Sep 07, 2022
|
Sell 62.8 K USD
|
Thomas James D
Chief Accounting Officer |
- 1602
|
39.19 USD |
|
2 years ago
Aug 25, 2022
|
Sell 524 K USD
|
NAPIERSKI RYAN S
President and CEO |
- 12251
|
42.76 USD |
|
2 years ago
Aug 25, 2022
|
Sell 551 K USD
|
NAPIERSKI RYAN S
President and CEO |
- 12749
|
43.22 USD |
|
2 years ago
Aug 22, 2022
|
Sell 45 K USD
|
LIPMAN ANDREW D
director: |
- 1000
|
45.01 USD |
|
2 years ago
Aug 18, 2022
|
Sell 257 K USD
|
Hatchett Steven Keith
Chief Product Officer |
- 5500
|
46.78 USD |
|
2 years ago
Jul 22, 2022
|
Sell 43 K USD
|
LIPMAN ANDREW D
director: |
- 1000
|
43 USD |
|
2 years ago
Jun 23, 2022
|
Sell 97.9 K USD
|
LUND STEVEN
Exec. Chairman of the Board |
- 2175
|
45.02 USD |
|
2 years ago
Jun 22, 2022
|
Sell 44.1 K USD
|
LIPMAN ANDREW D
director: |
- 1000
|
44.06 USD |
|
2 years ago
Jun 17, 2022
|
Sell 18 K USD
|
LUND STEVEN
Exec. Chairman of the Board |
- 400
|
45.01 USD |
|
2 years ago
Jun 13, 2022
|
Sell 9 K USD
|
LUND STEVEN
Exec. Chairman of the Board |
- 200
|
45 USD |
|
2 years ago
Jun 06, 2022
|
Sell 276 K USD
|
Lawrence Mark H
Chief Financial Officer |
- 5868
|
47.03 USD |
|
2 years ago
Jun 01, 2022
|
Sell 330 K USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 7025
|
46.97 USD |
|
2 years ago
May 25, 2022
|
Sell 421 K USD
|
NAPIERSKI RYAN S
President and CEO |
- 9452
|
44.55 USD |
|
2 years ago
May 25, 2022
|
Sell 702 K USD
|
NAPIERSKI RYAN S
President and CEO |
- 15548
|
45.13 USD |
|
2 years ago
May 23, 2022
|
Sell 45 K USD
|
LIPMAN ANDREW D
director: |
- 1000
|
44.95 USD |
|
2 years ago
May 16, 2022
|
Sell 42.6 K USD
|
LUND STEVEN
Exec. Chairman of the Board |
- 925
|
46.07 USD |
|
2 years ago
Apr 22, 2022
|
Sell 47.7 K USD
|
LIPMAN ANDREW D
director: |
- 1000
|
47.72 USD |
|
2 years ago
Mar 22, 2022
|
Sell 47.4 K USD
|
LIPMAN ANDREW D
director: |
- 1000
|
47.4 USD |
|
2 years ago
Mar 02, 2022
|
Sell 42.9 K USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 923
|
46.53 USD |
|
2 years ago
Mar 01, 2022
|
Sell 1.28 M USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 28280
|
45.21 USD |
|
2 years ago
Mar 01, 2022
|
Sell 13.7 K USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 297
|
46.04 USD |
|
2 years ago
Feb 25, 2022
|
Sell 839 K USD
|
NAPIERSKI RYAN S
President and CEO |
- 17747
|
47.28 USD |
|
2 years ago
Feb 25, 2022
|
Sell 346 K USD
|
NAPIERSKI RYAN S
President and CEO |
- 7253
|
47.7 USD |
|
2 years ago
Feb 22, 2022
|
Sell 53.3 K USD
|
LIPMAN ANDREW D
Director |
- 1000
|
53.27 USD |
|
2 years ago
Jan 24, 2022
|
Sell 50.5 K USD
|
LIPMAN ANDREW D
Director |
- 1000
|
50.5 USD |
|
3 years ago
Oct 05, 2021
|
Sell 66.8 K USD
|
Bettinger Jeffrey Clark
SVP, People and Places Officer |
- 1625
|
41.1 USD |
|
3 years ago
Sep 13, 2021
|
Sell 759 K USD
|
CHANG JOSEPH Y
EVP, Chief Scientific Officer |
- 16000
|
47.41 USD |
|
3 years ago
Jul 02, 2021
|
Sell 341 K USD
|
DORNY D MATTHEW
General Counsel |
- 6000
|
56.87 USD |
|
3 years ago
Jul 02, 2021
|
Sell 11.5 K USD
|
DORNY D MATTHEW
General Counsel |
- 200
|
57.3 USD |
|
3 years ago
Jun 16, 2021
|
Sell 894 K USD
|
WOOD RITCH N
Chief Executive Officer |
- 15214
|
58.74 USD |
|
3 years ago
Jun 16, 2021
|
Sell 180 K USD
|
WOOD RITCH N
Chief Executive Officer |
- 3036
|
59.4 USD |
|
3 years ago
Jun 17, 2021
|
Sell 933 K USD
|
WOOD RITCH N
Chief Executive Officer |
- 16348
|
57.08 USD |
|
3 years ago
Jun 17, 2021
|
Sell 110 K USD
|
WOOD RITCH N
Chief Executive Officer |
- 1902
|
57.94 USD |
|
3 years ago
Jun 01, 2021
|
Sell 377 K USD
|
DORNY D MATTHEW
General Counsel |
- 6200
|
60.78 USD |
|
3 years ago
May 21, 2021
|
Sell 637 K USD
|
Thomas James D
Chief Accounting Officer |
- 10619
|
60 USD |
|
3 years ago
May 11, 2021
|
Sell 164 K USD
|
DORNY D MATTHEW
General Counsel |
- 2800
|
58.51 USD |
|
3 years ago
May 11, 2021
|
Sell 201 K USD
|
DORNY D MATTHEW
General Counsel |
- 3400
|
59.25 USD |
|
3 years ago
May 06, 2021
|
Sell 27.5 K USD
|
Lawrence Mark H
Chief Financial Officer |
- 500
|
55 USD |
|
3 years ago
Apr 27, 2021
|
Sell 44 K USD
|
Lawrence Mark H
Chief Financial Officer |
- 800
|
55.02 USD |
|
3 years ago
Apr 21, 2021
|
Sell 118 K USD
|
Lawrence Mark H
Chief Financial Officer |
- 2148
|
55.02 USD |
|
3 years ago
Apr 01, 2021
|
Sell 330 K USD
|
DORNY D MATTHEW
General Counsel |
- 6200
|
53.16 USD |
|
3 years ago
Mar 15, 2021
|
Sell 199 K USD
|
NAPIERSKI RYAN S
President |
- 3824
|
51.93 USD |
|
3 years ago
Mar 15, 2021
|
Sell 236 K USD
|
NAPIERSKI RYAN S
President |
- 4481
|
52.61 USD |
|
3 years ago
Mar 15, 2021
|
Sell 90.5 K USD
|
NAPIERSKI RYAN S
President |
- 1695
|
53.4 USD |
|
3 years ago
Mar 09, 2021
|
Sell 32.3 K USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 626
|
51.55 USD |
|
3 years ago
Mar 01, 2021
|
Sell 343 K USD
|
DORNY D MATTHEW
General Counsel |
- 6629
|
51.71 USD |
|
3 years ago
Mar 01, 2021
|
Sell 303 K USD
|
DORNY D MATTHEW
General Counsel |
- 5771
|
52.53 USD |
|
3 years ago
Feb 18, 2021
|
Bought 250 K USD
|
CAMPBELL DANIEL W
Director |
+ 5055
|
49.49 USD |
|
3 years ago
Feb 18, 2021
|
Bought 250 K USD
|
CAMPBELL DANIEL W
Director |
+ 5055
|
49.48 USD |
|
3 years ago
Feb 18, 2021
|
Sell 56 K USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 1125
|
49.77 USD |
|
3 years ago
Feb 17, 2021
|
Bought 251 K USD
|
CAMPBELL DANIEL W
Director |
+ 4955
|
50.6 USD |
|
3 years ago
Feb 17, 2021
|
Bought 251 K USD
|
CAMPBELL DANIEL W
Director |
+ 4955
|
50.69 USD |
|
3 years ago
Feb 17, 2021
|
Bought 1 M USD
|
LUND STEVEN
Exec. Chairman of the Board |
+ 20850
|
48.05 USD |
|
3 years ago
Feb 16, 2021
|
Sell 220 K USD
|
NAPIERSKI RYAN S
President |
- 4510
|
48.73 USD |
|
3 years ago
Feb 16, 2021
|
Sell 109 K USD
|
NAPIERSKI RYAN S
President |
- 2190
|
49.57 USD |
|
3 years ago
Feb 16, 2021
|
Sell 15.1 K USD
|
NAPIERSKI RYAN S
President |
- 300
|
50.38 USD |
|
4 years ago
Nov 17, 2020
|
Sell 133 K USD
|
WOODBURY EDWINA D
Director |
- 2500
|
53.16 USD |
|
3 years ago
Jan 20, 2021
|
Sell 600 K USD
|
NAPIERSKI RYAN S
President |
- 10156
|
59.12 USD |
|
3 years ago
Jan 15, 2021
|
Sell 388 K USD
|
NAPIERSKI RYAN S
President |
- 7000
|
55.45 USD |
|
3 years ago
Jan 07, 2021
|
Sell 286 K USD
|
NAPIERSKI RYAN S
President |
- 4844
|
59.05 USD |
|
3 years ago
Jan 04, 2021
|
Sell 295 K USD
|
DORNY D MATTHEW
General Counsel |
- 5365
|
54.95 USD |
|
3 years ago
Jan 04, 2021
|
Sell 46.3 K USD
|
DORNY D MATTHEW
General Counsel |
- 835
|
55.48 USD |
|
3 years ago
Dec 15, 2020
|
Sell 357 K USD
|
NAPIERSKI RYAN S
President |
- 7000
|
50.97 USD |
|
3 years ago
Dec 01, 2020
|
Sell 217 K USD
|
DORNY D MATTHEW
General Counsel |
- 4300
|
50.42 USD |
|
3 years ago
Dec 01, 2020
|
Sell 77.3 K USD
|
DORNY D MATTHEW
General Counsel |
- 1500
|
51.54 USD |
|
3 years ago
Dec 01, 2020
|
Sell 20.9 K USD
|
DORNY D MATTHEW
General Counsel |
- 400
|
52.2 USD |
|
3 years ago
Dec 01, 2020
|
Sell 202 K USD
|
Lawrence Mark H
Chief Financial Officer |
- 3993
|
50.61 USD |
|
4 years ago
Nov 16, 2020
|
Sell 364 K USD
|
NAPIERSKI RYAN S
President |
- 7000
|
51.99 USD |
|
4 years ago
Nov 11, 2020
|
Sell 14.8 K USD
|
DORNY D MATTHEW
|
- 300
|
49.22 USD |
|
4 years ago
Nov 11, 2020
|
Sell 113 K USD
|
DORNY D MATTHEW
|
- 2219
|
50.85 USD |
|
4 years ago
Nov 11, 2020
|
Sell 189 K USD
|
DORNY D MATTHEW
|
- 3681
|
51.47 USD |
|
4 years ago
Oct 15, 2020
|
Sell 297 K USD
|
NAPIERSKI RYAN S
President |
- 5465
|
54.42 USD |
|
4 years ago
Oct 15, 2020
|
Sell 84.3 K USD
|
NAPIERSKI RYAN S
President |
- 1535
|
54.92 USD |
|
4 years ago
Oct 02, 2020
|
Sell 451 K USD
|
NAPIERSKI RYAN S
President |
- 8300
|
54.28 USD |
|
4 years ago
Oct 02, 2020
|
Sell 88.5 K USD
|
NAPIERSKI RYAN S
President |
- 1600
|
55.31 USD |
|
4 years ago
Oct 02, 2020
|
Sell 5.63 K USD
|
NAPIERSKI RYAN S
President |
- 100
|
56.3 USD |
|
4 years ago
Sep 23, 2020
|
Sell 136 K USD
|
DORNY D MATTHEW
General Counsel |
- 2666
|
51.01 USD |
|
4 years ago
Sep 23, 2020
|
Sell 163 K USD
|
DORNY D MATTHEW
General Counsel |
- 3131
|
52.13 USD |
|
4 years ago
Sep 23, 2020
|
Sell 21.4 K USD
|
DORNY D MATTHEW
General Counsel |
- 403
|
53.07 USD |
|
4 years ago
Sep 24, 2020
|
Sell 1.13 M USD
|
NAPIERSKI RYAN S
President |
- 22000
|
51.18 USD |
|
4 years ago
Sep 09, 2020
|
Sell 496 K USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 9931
|
49.92 USD |
|
4 years ago
Sep 10, 2020
|
Sell 269 K USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 5308
|
50.69 USD |
|
4 years ago
Sep 10, 2020
|
Sell 80.4 K USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 1561
|
51.48 USD |
|
4 years ago
Aug 17, 2020
|
Sell 236 K USD
|
NAPIERSKI RYAN S
|
- 5000
|
47.24 USD |
|
4 years ago
Jun 05, 2020
|
Sell 1.4 M USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 34970
|
40.01 USD |
|
4 years ago
Mar 20, 2020
|
Bought 202 K USD
|
WOOD RITCH N
Chief Executive Officer |
+ 10000
|
20.25 USD |
|
5 years ago
Jan 02, 2019
|
Sell 75.8 K USD
|
DORNY D MATTHEW
General Counsel |
- 1250
|
60.6 USD |
|
5 years ago
Dec 03, 2018
|
Sell 109 K USD
|
DORNY D MATTHEW
General Counsel |
- 1614
|
67.29 USD |
|
5 years ago
Dec 03, 2018
|
Sell 60.2 K USD
|
DORNY D MATTHEW
General Counsel |
- 886
|
67.97 USD |
|
6 years ago
Nov 12, 2018
|
Sell 91 K USD
|
DORNY D MATTHEW
General Counsel |
- 1400
|
65.01 USD |
|
6 years ago
Nov 12, 2018
|
Sell 72.3 K USD
|
DORNY D MATTHEW
General Counsel |
- 1100
|
65.75 USD |
|
6 years ago
Oct 01, 2018
|
Sell 205 K USD
|
DORNY D MATTHEW
General Counsel |
- 2500
|
82.18 USD |
|
6 years ago
Sep 04, 2018
|
Sell 8.07 K USD
|
DORNY D MATTHEW
General Counsel |
- 100
|
80.74 USD |
|
6 years ago
Sep 04, 2018
|
Sell 192 K USD
|
DORNY D MATTHEW
General Counsel |
- 2400
|
79.87 USD |
|
6 years ago
Aug 10, 2018
|
Sell 290 K USD
|
DORNY D MATTHEW
General Counsel |
- 3550
|
81.8 USD |
|
6 years ago
Aug 10, 2018
|
Sell 16.5 K USD
|
DORNY D MATTHEW
General Counsel |
- 200
|
82.58 USD |
|
6 years ago
Aug 09, 2018
|
Sell 50.4 K USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 600
|
84.02 USD |
|
6 years ago
Aug 08, 2018
|
Sell 820 K USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 10000
|
82.02 USD |
|
6 years ago
Aug 03, 2018
|
Sell 800 K USD
|
NAPIERSKI RYAN S
President |
- 10000
|
80 USD |
|
6 years ago
Aug 07, 2018
|
Sell 716 K USD
|
CHANG JOSEPH Y
Chief Scientific Officer |
- 8500
|
84.21 USD |
|
6 years ago
Aug 06, 2018
|
Sell 425 K USD
|
WOODBURY EDWINA D
Director |
- 5000
|
85.02 USD |
|
6 years ago
Jul 02, 2018
|
Sell 181 K USD
|
DORNY D MATTHEW
General Counsel |
- 2331
|
77.47 USD |
|
6 years ago
Jul 02, 2018
|
Sell 91.2 K USD
|
DORNY D MATTHEW
General Counsel |
- 1169
|
78.02 USD |
|
6 years ago
Jun 07, 2018
|
Sell 572 K USD
|
OFFEN NEIL H
Director |
- 7000
|
81.66 USD |
|
6 years ago
Jun 01, 2018
|
Sell 180 K USD
|
DORNY D MATTHEW
General Counsel |
- 2197
|
82.09 USD |
|
6 years ago
Jun 01, 2018
|
Sell 108 K USD
|
DORNY D MATTHEW
General Counsel |
- 1303
|
83 USD |
|
6 years ago
May 10, 2018
|
Sell 269 K USD
|
DORNY D MATTHEW
General Counsel |
- 3500
|
76.87 USD |
|
6 years ago
May 03, 2018
|
Sell 960 K USD
|
DORNY D MATTHEW
General Counsel |
- 13000
|
73.81 USD |
|
6 years ago
Apr 04, 2018
|
Sell 150 K USD
|
DORNY D MATTHEW
General Counsel |
- 2000
|
75 USD |
|
6 years ago
Apr 04, 2018
|
Sell 1.68 M USD
|
LUND STEVEN
Exec. Chairman of the Board |
- 22349
|
75.01 USD |
|
6 years ago
Apr 05, 2018
|
Sell 4.02 M USD
|
LUND STEVEN
Exec. Chairman of the Board |
- 53651
|
75 USD |
|
6 years ago
Apr 04, 2018
|
Sell 375 K USD
|
LUND STEVEN
Exec. Chairman of the Board |
- 5000
|
75 USD |
|
6 years ago
Apr 02, 2018
|
Sell 184 K USD
|
DORNY D MATTHEW
General Counsel |
- 2549
|
72.05 USD |
|
6 years ago
Apr 02, 2018
|
Sell 51.1 K USD
|
DORNY D MATTHEW
General Counsel |
- 701
|
72.84 USD |
7. News
Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation
Nu Skin Enterprises, Inc. demonstrates a tested business model with long-term free cash flow generation, supported by acquisitions, new products, and digital transformation. Despite recent earnings disappointments, optimistic 2025-2026 EPS growth projections and multiple revenue catalysts suggest significant upside potential in the company's valuation. The company's global market expansion, cash acquisitions of LifeDNA and BeautyBio, and innovative product launches are key drivers for future net sales growth.
seekingalpha.com
- 5 days ago
Nu Skin Q3 Earnings & Sales Miss Estimates, 2024 Guidance Cut
NUS' Q3 results show lower earnings and net sales amid macroeconomic pressures and challenges in the direct selling industry. Management lowers 2024 view.
zacks.com
- 1 week ago
Nu Skin Enterprises, Inc. (NUS) Q3 2024 Earnings Call Transcript
Nu Skin Enterprises, Inc. (NYSE:NUS ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Scott Pond - Vice President-Investor Relations Ryan Napierski - President and Chief Executive Officer James Thomas - Chief Financial Officer Conference Call Participants Chasen Bender - Citigroup Ashley Helgans - Jefferies Operator Thank you for standing by. My name is Prilla, and I will be your conference operator today.
seekingalpha.com
- 1 week ago
Nu Skin Enterprises (NUS) Lags Q3 Earnings and Revenue Estimates
Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.56 per share a year ago.
zacks.com
- 1 week ago
4 Cosmetics Stocks Worth Watching Despite Industry Challenges
The Zacks Cosmetics industry is navigating a tough shopping environment. Nevertheless, COTY, Helen of Troy, European Wax Center and Nu Skin are leveraging innovations.
zacks.com
- 1 week ago
Nu Skin's Q3 Earnings Coming Up: Here's What You Should Know
NUS' Q3 results are likely to reflect the impacts of macroeconomic hurdles on consumer spending and customer acquisition.
zacks.com
- 1 week ago
Later Drives Full-Funnel Influencer Marketing Impact with New Affiliate Campaign Capabilities, Leveraging a Strategic Partnership with Mavely
Today's announcement continues the company's vision of driving predictable outcomes for social commerce. BOSTON , Oct. 22, 2024 /PRNewswire/ -- Later , a leading social media and influencer marketing partner for Fortune 5000 brands, partners with Mavely , the Everyday Influencer Platform®, to bring affiliate capabilities to creator campaigns.
prnewswire.com
- 3 weeks ago
FPT and National University of Singapore Join Forces in Driving AI Innovation and Fostering Talent Development
SINGAPORE--(BUSINESS WIRE)--The National University of Singapore's School of Computing (NUS Computing) has entered into a partnership with FPT, a leading global technology corporation based in Vietnam, to advance the field of artificial intelligence (AI). This collaboration plans a joint investment of US$50 million, to be contributed by FPT, NUS, and other key players in the local and regional AI ecosystems over the next five years, aiming to drive pioneering research in AI and enhance talent d.
businesswire.com
- 3 weeks ago
Nu Skin: Betting On A Potential Comeback
Nu Skin Enterprises is at a potential inflection point with seemingly stabilized revenue. Management's restructuring and innovative product focus, particularly through the Rhyz business, show promise for a turnaround and long-term growth. A strong balance sheet and steady cash flow support the business, reducing bankruptcy risk and enabling strategic pivots and shareholder rewards.
seekingalpha.com
- 3 weeks ago
Nu Skin Navigates Growth With Innovation Amid Industry Challenges
NUS drives growth through strategic initiatives, innovative product launches like MYND360 and the expanding Rhyz business amid macroeconomic woes.
zacks.com
- 1 month ago
NUS Stock Dips as Nu Skin Enterprises Faces Financial Challenges
Nu Skin Enterprises (NUS, Financial) experienced a significant stock price drop, decreasing by 5.12%. The stock is currently valued at $6.12 per share with a trading volume of 298,721 shares and a turnover rate of 0.60%.
gurufocus.com
- 1 month ago
Mavely Streamlines Creator Experience from Post to Purchase with New LinkDM and Button Partnerships and MyShop Upgrades
Creators can now unlock best-in-class content creation and monetization tools for an easy workflow, big cost savings, and increased revenue CHICAGO , Oct. 9, 2024 /PRNewswire/ -- Mavely , the Everyday Influencer Platform®, today announced two new integrations for creators within their platform in partnership with LinkDM and Button , as well as updates to their influencer storefront product Mavely MyShop . These integrations add to Mavely's robust suite of tools and give Mavely creators access to critical technology for free, with exclusive feature expansions – helping them execute smarter and more powerful content creation while realizing thousands of dollars in cost savings each year.
prnewswire.com
- 1 month ago
8. Profile Summary
Nu Skin Enterprises, Inc. NUS
COUNTRY
US
INDUSTRY
Household & Personal Products
MARKET CAP
$ 377 M
Dividend Yield
0.81%
Description
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Contact
75 West Center Street, Provo, UT, 84601
https://www.nuskin.com
IPO Date
Nov. 22, 1996
Employees
3700
Officers
Mr. Chayce David Clark
Executive Vice President & General Counsel
Mr. Ryan S. Napierski
President, Chief Executive Officer & Director
Mr. Scott Pond
Vice President of Investor Relations
Mr. Steve Keith Hatchett
Executive Vice President & Chief Product Officer
Dr. Joseph Y. Chang Ph.D.
Executive Vice President & Chief Scientific Officer
Mr. Blake M. Roney
Founder
Mr. Mark L. Adams
Chief Information Officer
Ms. Sandra N. Tillotson
Founder
Mr. James D. Thomas
Executive Vice President, Chief Accounting Officer & Chief Financial Officer
Mr. Joe Sueper
Senior Vice President & Chief Technology Officer